Published in J Pediatr (Rio J) on April 02, 2010
Fetuin-A levels in obesity: differences in relation to metabolic syndrome and correlation with clinical and laboratory variables. Arch Med Sci (2012) 0.85
A pilot study on metabolic syndrome and its associated features among Qatari schoolchildren. Int J Gen Med (2011) 0.84
Evaluation of Body Mass Index (BMI) Percentile cut-off Levels with Reference to Insulin Resistance: A Comparative Study on South Indian Obese and Non-Obese Adolescents. J Clin Diagn Res (2013) 0.81
Prevalence of overweight and obesity in children and adolescents from the age range of 2 to 19 years old in Brazil. Int J Pediatr (2014) 0.79
Hypertriglyceridemic waist and metabolic abnormalities in Brazilian schoolchildren. PLoS One (2014) 0.78
Obesity in patients with Bardet-Biedl syndrome: influence of appetite-regulating hormones. Pediatr Nephrol (2012) 0.75
Metabolic syndrome's risk factors and its association with nutritional status in schoolchildren. Prev Med Rep (2017) 0.75
Hypertriglyceridemic Waist Phenotype and Changes in the Fasting Glycemia and Blood Pressure in Children and Adolescents Over One-Year Follow-Up Period. Arq Bras Cardiol (2017) 0.75
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med (2015) 11.05
Effects of weight loss on asthma control in obese patients with severe asthma. Eur Respir J (2013) 2.25
Fasting breath hydrogen concentration in short bowel syndrome patients with colon incontinuity before and after antibiotic therapy. Nutrition (2004) 2.01
Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35: an analysis of 454 consecutive patients. World J Surg (2011) 1.52
Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21-34 kg/m(2). Surg Obes Relat Dis (2009) 1.51
Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. J Gastroenterol Hepatol (2007) 1.39
Weight loss improves neurovascular and muscle metaboreflex control in obesity. Am J Physiol Heart Circ Physiol (2003) 1.28
Surgical treatment of type 2 diabetes in patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases. J Gastrointest Surg (2012) 1.10
Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms. J Gastrointest Surg (2011) 1.05
Abnormal neurovascular control during sympathoexcitation in obesity. Obes Res (2003) 1.02
Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal-jejunal bypass liner. Diabetes Technol Ther (2011) 1.01
Diet and exercise training restore blood pressure and vasodilatory responses during physiological maneuvers in obese children. Circulation (2005) 1.00
Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol Trace Elem Res (2006) 0.98
Gly16 + Glu27 beta2-adrenoceptor polymorphisms cause increased forearm blood flow responses to mental stress and handgrip in humans. J Appl Physiol (1985) (2005) 0.97
Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration (2009) 0.97
Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen. Maturitas (2003) 0.95
Intra-abdominal thickness by ultrasonography to predict risk factors for cardiovascular disease and its correlation with anthropometric measurements. Metabolism (2002) 0.92
Effects of perilipin (PLIN) gene variation on metabolic syndrome risk and weight loss in obese children and adolescents. J Clin Endocrinol Metab (2008) 0.90
Impact of adiposity on immunological parameters. Arq Bras Endocrinol Metabol (2009) 0.89
Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner. Obes Surg (2011) 0.89
Calcium intake and metabolic bone disease after eight years of Roux-en-Y gastric bypass. Obes Surg (2008) 0.87
Bariatric surgery reverses natural killer (NK) cell activity and NK-related cytokine synthesis impairment induced by morbid obesity. Obes Surg (2011) 0.87
Blood pressure measurement in obese patients: comparison between upper arm and forearm measurements. Blood Press Monit (2004) 0.87
Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg (2005) 0.87
[Obesity and coronary artery disease: role of vascular inflammation]. Arq Bras Cardiol (2010) 0.85
[Metabolic Syndrome in professional truck drivers who work on Highway BR-116 within the area of São Paulo City - Régis Bittencourt]. Arq Bras Endocrinol Metabol (2008) 0.85
Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) -- preliminary findings. Obes Surg (2005) 0.85
Binge eating symptoms, diet composition and metabolic characteristics of obese children and adolescents. Appetite (2007) 0.84
Follow-up of Roux-en-Y gastric bypass patients at 5 or more years postoperatively. Obes Surg (2007) 0.83
[Case report: recently diagnosed celiac disease as aggravating factor of osteoporosis in an old woman]. Arq Bras Endocrinol Metabol (2006) 0.83
Basal energy expenditure and diet- induced modifications to thermogenesis in short bowel syndrome. Clin Nutr (2005) 0.82
[Characterization of metabolic resting rate and proposal of a new equation for a female Brazilian population]. Arq Bras Endocrinol Metabol (2010) 0.82
[Obstructive sleep apnea contribution to oxidative stress in obesity]. Arq Bras Endocrinol Metabol (2008) 0.82
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications. Expert Opin Drug Saf (2015) 0.82
Multidisciplinary approach to morbidly obese patients undergoing surgical treatment by adjustable gastric banding. Rev Col Bras Cir (2010) 0.81
Investigational therapies in the treatment of obesity. Expert Opin Investig Drugs (2006) 0.81
Effect of surgery-induced weight loss on immune function. Expert Rev Gastroenterol Hepatol (2008) 0.81
Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles. Obesity (Silver Spring) (2006) 0.81
[Role of zinc in insulin resistance]. Arq Bras Endocrinol Metabol (2004) 0.80
Long-term pharmacotherapy for obesity in elderly patients: a retrospective evaluation of medical records from a specialized obesity outpatient clinic. Drugs Aging (2010) 0.80
Impact on dyslipidemia of the laparoscopic ileal interposition associated to sleeve gastrectomy in type 2 diabetic patients. J Gastrointest Surg (2010) 0.79
Systemic hypertension, diabetes mellitus, and dyslipidemia in relation to body mass index: evaluation of a Brazilian population. Rev Hosp Clin Fac Med Sao Paulo (2004) 0.79
Lack of mutations in the leptin receptor gene in severely obese children. Arq Bras Endocrinol Metabol (2012) 0.78
[Metabolic profile according to leptin levels in obese patients]. Arq Bras Endocrinol Metabol (2007) 0.78
Metformin in normal-weight hirsute women with polycystic ovary syndrome with normal insulin sensitivity. Gynecol Endocrinol (2007) 0.78
Fixed-dose combination of phentermine-topiramate for the treatment of obesity. Expert Rev Clin Pharmacol (2013) 0.78
Surgical treatment of morbid obesity: mid-term outcomes of the laparoscopic ileal interposition associated to a sleeve gastrectomy in 120 patients. Obes Surg (2011) 0.78
Orlistat in the prevention of diabetes in the obese patient. Vasc Health Risk Manag (2008) 0.78
Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel mutation in arginine-vasopressin gene in a Brazilian family. Arq Bras Endocrinol Metabol (2008) 0.77
[Hormonal axes in obesity: cause or effect?]. Arq Bras Endocrinol Metabol (2007) 0.76
Associations between a common variant near the MC4R gene and serum triglyceride levels in an obese pediatric cohort. Endocrine (2015) 0.76
Pharmacological treatment of obesity. Arq Bras Endocrinol Metabol (2006) 0.76
Changes in neuropsychological tests and brain metabolism after bariatric surgery. J Clin Endocrinol Metab (2014) 0.76
The N363S polymorphism in the glucocorticoid receptor gene: effects on visceral fat assessed by abdominal computed tomography. Arq Bras Endocrinol Metabol (2009) 0.76
Results of biliopancreatic diversion in two patients with Prader-Willi syndrome. Obes Surg (2005) 0.76
Body composition alterations, energy expenditure and fat oxidation in elderly males suffering from prostate cancer, pre and post orchiectomy. Clinics (Sao Paulo) (2009) 0.76
Bupropion/naltrexone fixed-dose combination for the treatment of obesity. Drugs Today (Barc) (2011) 0.76
[Analysis of resting metabolic rate evaluated by indirect calorimetry in obese women with low and high caloric intake]. Arq Bras Endocrinol Metabol (2008) 0.76
[Therapeutical approach of obesity in Prader-Willi Syndrome]. Arq Bras Endocrinol Metabol (2007) 0.75
[The Internet as a tool to treat an overweight population]. Arq Bras Endocrinol Metabol (2005) 0.75
[Recent progress and novel perspectives on obesity pharmacotherapy]. Arq Bras Endocrinol Metabol (2010) 0.75
Short-term use of liraglutide in the management of patients with weight regain after bariatric surgery. Rev Col Bras Cir (2013) 0.75
[Effects of growth hormone on anthropometric and metabolic parameters in android obesity]. Arq Bras Endocrinol Metabol (2006) 0.75
Why are anti-obesity drugs stigmatized? Expert Opin Drug Saf (2014) 0.75
THE MASTICATORY SYSTEM OF THE OBESE: CLINICAL AND ELECTROMYOGRAPHIC EVALUATION. Int J Orofacial Myology (2014) 0.75
[Obese children lipid profile: effects of hypocaloric diet and aerobic physical exercise]. Arq Bras Endocrinol Metabol (2006) 0.75